Verona Pharma plc Sponsored ADR Stock
Verona Pharma plc Sponsored ADR Stock price
Key metrics
| Market capitalization | $3.25b |
| Enterprise Value | $3.14b |
| P/E (TTM) P/E ratio | negative |
| EV/FCF (TTM) EV/FCF | negative |
| EV/Sales (TTM) EV/Sales | 552.00 |
| P/S ratio (TTM) P/S ratio | 571.67 |
| P/B ratio (TTM) P/B ratio | 24.88 |
| Revenue growth (TTM) Revenue growth | 1,131.31% |
| Revenue (TTM) Revenue | $5.68m |
Is Verona Pharma plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
Verona Pharma plc Sponsored ADR Stock Analysis
Analyst Opinions
8 Analysts have issued a Verona Pharma plc Sponsored ADR forecast:
Analyst Opinions
8 Analysts have issued a Verona Pharma plc Sponsored ADR forecast:
Financial data from Verona Pharma plc Sponsored ADR
| Sep '24 |
+/-
%
|
||
| Revenue | 5.68 5.68 |
1,135%
1,135%
|
|
| Gross Profit | 4.12 4.12 |
908%
908%
|
|
| EBITDA | -155 -155 |
145%
145%
|
EBIT (Operating Income) EBIT | -156 -156 |
145%
145%
|
| Net Profit | -154 -154 |
203%
203%
|
|
In millions USD.
Don't miss a Thing! We will send you all news about Verona Pharma plc Sponsored ADR directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Verona Pharma plc Sponsored ADR Stock News
Company Profile
Verona Pharma Plc operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. Its lead product candidate, ensifentrine, has the potential to be the first therapy for the treatment of respiratory diseases that combines bronchodilator and anti-inflammatory activities in one compound. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
| Head office | United Kingdom |
| CEO | David Zaccardelli |
| Employees | 79 |
| Founded | 2005 |
| Website | www.veronapharma.com |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
